Piper Jaffray Raises Price Target on Vascular Solutions (VASC) to $49 Following 2Q Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Vascular Solutions Reports Second Quarter Results
July 25, 2016 4:05 PM EDTRevenue increased 10% to $41.2 million, in the top half of guidance rangeAdjusted EPS of $0.33, with corresponding GAAP EPS of $0.31, at the top end of guidanceRaising 2016 revenue guidance to $164 - $166 million, representing an increase of 12% at the midpointRaising 2016 adjusted EPS guidance to $1.22 - $1.26, representing an increase of 12% at the midpoint, with corresponding 2016 GAAP EPS guidance of $0.94 - $0.98
MINNEAPOLIS, July 25, 2016 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq: VASC) today reported financial results for the second quarter ended June 30,... More
